LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,282,000 | +9.4% | 85,990 | -1.3% | 1.46% | +4.1% |
Q3 2021 | $12,136,000 | +406.9% | 87,110 | +377.4% | 1.40% | +424.3% |
Q2 2021 | $2,394,000 | +12.3% | 18,245 | +30.5% | 0.27% | +8.5% |
Q1 2021 | $2,132,000 | -74.9% | 13,985 | -77.7% | 0.25% | -78.4% |
Q4 2018 | $8,504,000 | -33.0% | 62,671 | +35.6% | 1.14% | -0.7% |
Q3 2018 | $12,686,000 | -20.7% | 46,217 | -40.2% | 1.15% | -21.8% |
Q2 2018 | $16,004,000 | +14.5% | 77,247 | -8.7% | 1.47% | +7.3% |
Q1 2018 | $13,982,000 | -4.5% | 84,652 | -20.8% | 1.37% | +32.7% |
Q4 2017 | $14,634,000 | -24.1% | 106,887 | -24.5% | 1.03% | -18.6% |
Q3 2017 | $19,283,000 | -8.3% | 141,626 | -18.3% | 1.27% | -9.9% |
Q2 2017 | $21,039,000 | +14.0% | 173,291 | -0.7% | 1.41% | +15.0% |
Q1 2017 | $18,463,000 | +2.2% | 174,456 | -1.9% | 1.23% | +10.3% |
Q4 2016 | $18,064,000 | -14.7% | 177,771 | -14.3% | 1.11% | -10.6% |
Q3 2016 | $21,182,000 | +1.3% | 207,496 | +18.3% | 1.24% | +2.1% |
Q2 2016 | $20,912,000 | – | 175,331 | – | 1.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |